Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc. - Seite 2

The Company is listed on the NASDAQ and the TSX, and currently trades on both exchanges under the ticker symbol “AEZS” (however, as noted above, the Company will begin trading on such exchanges under the ticker symbol “CSCI” effective as of August 9, 2024). For more information, please visit COSCIENS’ website at www.zentaris.com.

Forward-Looking Statements

The information in this news release has been prepared as of August 6, 2024. Certain statements in this news release, referred to herein as "forward-looking statements", constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended, and "forward-looking information" under the provisions of Canadian securities laws. All statements, other than statements of historical fact, that address circumstances, events, activities, or developments that could or may or will occur are forward-looking statements. When used in this news release, words such as "anticipate", "assume", "believe", "could", "expect", "forecast", "future", "goal", "guidance", "intend", "likely", "may", "would" or the negative or comparable terminology as well as terms usually used in the future and the conditional are generally intended to identify forward-looking statements, although not all forward-looking statements include such words. Forward-looking statements in this news release include, but are not limited to, statements relating to the Name Change, including the final approval of the Name Change for trading purposes by the TSX and the NASDAQ and the trading of the Common Shares on the TSX and NASDAQ under the trading symbol “CSCI” and concurrent cessation of trading under the trading symbol “AEZS”.

Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by the Company as of the date of such statements, are inherently subject to significant business, economic, operational and other risks, uncertainties, contingencies and other factors, including those described below, which could cause actual results, performance or achievements of the combined Company to be materially different from results, performance or achievements expressed or implied by such forward-looking statements and, as such, undue reliance must not be placed on them.